Hills Bank & Trust’s Novo Nordisk NVO Stock Holding History

Hills Bank & Trust’s Portfolio NVO Stock Details NVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-934	Closed	-$111K	–	311
2024 Q3	$111K	Hold	934	–	–	0.01%	292
2024 Q2	$133K	Buy	+934	New	+$124K	0.01%	267

Other funds holding NVO

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

GQG Partners Ft. Lauderdale, Florida $63.1B AUM 23.07% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Koshinski Asset Management Decatur, Illinois $1.6B AUM 20.7% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Fayez Sarofim & Co Houston, Texas $39.1B AUM 15.14% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return

Hills Bank & Trust's NVO Position: Q4 2024 in Review

Hills Bank & Trust sold out of Novo Nordisk (NVO) in Q4 2024, closing a stake of 934 shares — an estimated $111K sold.

Hills Bank & Trust first reported a position in NVO in Q2 2024 and held it in 2 quarters. The position peaked at $133K in Q2 2024. 1,663 funds tracked by Wall St. Rank hold NVO as of Q4 2024.

Hills Bank & Trust reported no remaining Novo Nordisk position as of Q4 2024 after selling out during the quarter.
Hills Bank & Trust sold 934 Novo Nordisk shares in Q4 2024, an estimated $111K.
Hills Bank & Trust first reported a position in Novo Nordisk in Q2 2024 and held it in 2 quarters.
Hills Bank & Trust's Novo Nordisk position peaked at $133K in Q2 2024.
1,663 funds tracked by Wall St. Rank held Novo Nordisk as of Q4 2024.

Based on Hills Bank & Trust's 13F filing for Q4 2024, filed 10 Feb 2025.